Abstract

Abstract:

The present disclosure relates to a process for the preparation of crystalline form of N-(Cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide dihydrochloride of formula-1a. The structure of formula-1a is shown below:

Formula-1a.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS